Please provide your email address to receive an email when new articles are posted on . The last time we had a new mechanism of action approved for topical use in psoriasis the movie “Titanic” was ...

Please provide your email address to receive an email when new articles are posted on . Topical steroids have remained a mainstay first-line treatment for psoriasis, but two new drugs in development ...

Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients. The American Academy of Dermatology/National Psoriasis Foundation ...

More recently, increased attention has been given to the use of the Goeckerman therapy in cases of severe psoriasis that have proven resistant to biologic therapy. The Goeckerman Regimen typically ...

Treatment with tapinarof 1%, a nonsteroidal topical cream in clinical development, was associated with durable control of plaque psoriasis in a 52-week phase 3 trial presented as a latebreaker at the ...

More than a third of patients with plaque psoriasis had complete or near-complete clearance with a first-in-class nonsteroidal topical therapy, results of two randomized trials showed. Once-daily ...

Plaque psoriasis is the most prevalent form of the disease. Unsightly skin can cause patients great anguish, raising their frustration with slow or ineffective therapies. This is the approach used by ...

SAN DIEGO--(BUSINESS WIRE)--Samumed presented at the 2016 American College of Rheumatology (ACR) Annual Meeting preclinical results from in vitro and in vivo studies regarding the use of its small ...

The Food and Drug Administration has accepted a new drug application (NDA) for roflumilast, a topical phosphodiesterase type 4 (PDE4) inhibitor for treating psoriasis in adults and adolescents, ...

The treatment of psoriasis—an autoimmune disease that creates red, scaly plaques on the skin—depends on multiple factors, but two big factors include the severity and the location of the symptoms, ...